Key facts
- This page summarizes Gregory L. Smith's Form 3 filing for Medtronic plc (MDT).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2022, 17:11.
Gregory L. Smith - 27 Jun 2022 Form 3 Insider Report for Medtronic plc (MDT)
- Reporting relationship
- EVP Global Ops & Supply Chain
- Issuer ticker
- MDT
- Reported as of
- 27 Jun 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 07 Jul 2022, 17:11:14 UTC
- Next SEC filing
- 03 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Thomas L. Osteraas, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gregory L. Smith filed Form 3 for Medtronic plc (MDT) on 07 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDT
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 28,905
- Date
- 27 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDT
holding
Derivative
Performance Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Performance Share Units
- Underlying amount
- 9,564
- Exercise price
- Footnotes
- F2, F3, F4
MDT
holding
Derivative
Performance Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Performance Share Units
- Underlying amount
- 8,317
- Exercise price
- Footnotes
- F2, F4, F5
MDT
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 30,837
- Exercise price
- $120.25
- Footnotes
- F6
MDT
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 31,028
- Exercise price
- $131.26
- Footnotes
- F6
MDT
holding
Derivative
Performance Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Jun 2022
- Ownership
- Direct
- Underlying class
- Performance Share Units
- Underlying amount
- 8,762
- Exercise price
- Footnotes
- F4, F7, F8
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 8 footnotes
Footnote F1
Includes 18,695 restricted stock units that vest on 4/5/23, 3,910 restricted stock units that vest on 8/23/23 and 3,564 restricted stock units that vest on 8/2/24.
Footnote F2
Vests on August 3, 2023.
Footnote F3
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,564 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Footnote F4
Each Performance Share Unit represents a contingent right to receive one share of Medtronic Common Stock.
Footnote F5
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,317 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
Footnote F6
These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Footnote F7
Vests on August 2, 2024.
Footnote F8
The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 8,762 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.